Referred Tests
| Web: | mayocliniclabs.com |
|---|---|
| Email: | mcl@mayo.edu |
| Telephone: | 800-533-1710 |
| International: | +1 855-379-3115 |
| Values are valid only on day of printing. | |
Test ID: RZIKU
Zika Virus, PCR, Molecular Detection, Random, Urine
Useful For 
Suggests clinical disorders or settings where the test may be helpful
Qualitative detection of Zika virus RNA in paired urine and serum from individuals meeting CDC Zika virus clinical or epidemiologic criteria
Highlights
Provides qualitative detection of Zika virus RNA from urine collected during the acute phase of infection.
This test is intended for the evaluation of pregnant women and symptomatic nonpregnant individuals with potential exposure to Zika virus.
Due to similar clinical presentations, testing for RNA or IgM-class antibodies to dengue and chikungunya viruses, concurrently with Zika virus testing, is strongly recommended.
For the most up-to-date Zika epidemiology and testing recommendations, visit www.cdc.gov/zika/
Testing Algorithm Delineates situations when tests are added to the initial order. This includes reflex and additional tests.
The FDA requires that urine specimens be tested in conjunction with a paired serum specimen; order RZIKS / Zika Virus, PCR, Molecular Detection, Serum for the paired serum specimen.
The following algorithms are available in Special Instructions:
-Assessment for Zika Virus Infection in Nonpregnant Individuals
Special Instructions Library of PDFs including pertinent information and forms related to the test
Method Name A short description of the method used to perform the test
Real-Time Reverse Transcription Polymerase Chain Reaction (PCR)/DNA Probe Hybridization
NY State Available Indicates the status of NY State approval and if the test is orderable for NY State clients.
Reporting Name Lists a shorter or abbreviated version of the Published Name for a test
Aliases Lists additional common names for a test, as an aid in searching
Vector-Borne Illness